Tech Company Financing Transactions
Addition Therapeutics Funding Round
Addition Therapeutics secured a $100 million funding round on 12/17/2025. Investors included Abingworth, Bill & Melinda Gates Foundation and Osage University Partners.
Transaction Overview
Company Name
Announced On
12/17/2025
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
We're on a mission to fulfill the promise of genomic medicine for all patients. With our breakthrough all-RNA PRINT� platform, we're forging new frontiers for what's possible in the treatment of both chronic and rare diseases. Today, only a small fraction of patients are able to take advantage of genomic medicine to treat their disease. At Addition, we're working to create a much different tomorrow.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ron Park
Browse more venture capital transactions:
Prev: 12/17/2025: Acosta venture capital transaction
Next: 12/17/2025: Cosan venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs